Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
GSK cuts losses on $700M upfront Alzheimer’s collab with Alector
GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both drugs involved flunk clinical trials.
James Waldron
Jul 9, 2026 7:30am
AstraZeneca pens $2.1B deal for challenger to Merck’s Ohtuvayre
Jul 8, 2026 5:00am
Boehringer bags viral vector platform for cancer vaccine R&D
Jul 7, 2026 10:35am
Genentech sees 103 layoffs, pens $490M breast cancer collab
Jul 6, 2026 7:30am
Fosun pays $32M to join Lilly and Novartis in psoriasis market
Jul 2, 2026 8:30am
Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE
Jun 30, 2026 8:00am
